These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29925915)

  • 1. A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach.
    Mehta SJ; Khan T; Guerra C; Reitz C; McAuliffe T; Volpp KG; Asch DA; Doubeni CA
    Am J Gastroenterol; 2018 Dec; 113(12):1848-1854. PubMed ID: 29925915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
    Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
    J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer Screening.
    Symonds EL; Hughes D; Flight I; Woodman R; Chen G; Ratcliffe J; Pedersen SK; Fraser RJL; Wilson CJ; Young GP
    Cancer Prev Res (Phila); 2019 Sep; 12(9):631-640. PubMed ID: 31266825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial.
    Mehta SJ; Pepe RS; Gabler NB; Kanneganti M; Reitz C; Saia C; Teel J; Asch DA; Volpp KG; Doubeni CA
    JAMA Netw Open; 2019 Mar; 2(3):e191156. PubMed ID: 30901053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screen to Save: Results from NCI's Colorectal Cancer Outreach and Screening Initiative to Promote Awareness and Knowledge of Colorectal Cancer in Racial/Ethnic and Rural Populations.
    Whitaker DE; Snyder FR; San Miguel-Majors SL; Bailey LO; Springfield SA
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):910-917. PubMed ID: 32358038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
    Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
    JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    Mehta SJ; Day SC; Norris AH; Sung J; Reitz C; Wollack C; Snider CK; Shaw PA; Asch DA
    BMJ; 2021 May; 373():n1022. PubMed ID: 34006604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
    Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
    J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Rescue" of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test Options.
    Young GP; Chen G; Wilson CJ; McGrane E; Hughes-Barton DL; Flight IHK; Symonds EL
    Cancer Prev Res (Phila); 2021 Aug; 14(8):803-810. PubMed ID: 34127509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
    Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic.
    Heijman RL; Stolte IG; Thiesbrummel HF; van Leent E; Coutinho RA; Fennema JS; Prins M
    Sex Transm Infect; 2009 Aug; 85(4):249-55. PubMed ID: 19103642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
    Platt KD; Kurlander JE; Zikmund-Fisher BJ; Lipson R; Knaus M; Waljee AK; Saini SD
    Am J Gastroenterol; 2019 Oct; 114(10):1685-1687. PubMed ID: 31464741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.